FDA Approved: HYDROXYUREA — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for HYDROXYUREA submitted by Endo USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Essential Thrombocythemia
• Myeloproliferative Neoplasms
• Polycythemia Vera
• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

SUPPL AP for HYDROXYUREA (HYDROXYUREA)